View in EDS

More than just another IDH inhibitor: Insights from the HMPL-306 phase 1 trial.

Saved in:
Bibliographic Details
Title: More than just another IDH inhibitor: Insights from the HMPL-306 phase 1 trial.
Authors: Getz TM; Section of Hematology, Department of Internal Medicine, Yale University and Yale Comprehensive Cancer Center, New Haven, CT 06520, USA., Bewersdorf JP; Section of Hematology, Department of Internal Medicine, Yale University and Yale Comprehensive Cancer Center, New Haven, CT 06520, USA. Electronic address: jan.bewersdorf@yale.edu.
Source: Med (New York, N.Y.) [Med] 2025 Jun 13; Vol. 6 (6), pp. 100600.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40516517
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: More than just another IDH inhibitor: Insights from the HMPL-306 phase 1 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Getz+TM%22">Getz TM</searchLink>; Section of Hematology, Department of Internal Medicine, Yale University and Yale Comprehensive Cancer Center, New Haven, CT 06520, USA.<br /><searchLink fieldCode="AU" term="%22Bewersdorf+JP%22">Bewersdorf JP</searchLink>; Section of Hematology, Department of Internal Medicine, Yale University and Yale Comprehensive Cancer Center, New Haven, CT 06520, USA. Electronic address: jan.bewersdorf@yale.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769215%22">Med (New York, N.Y.)</searchLink> [Med] 2025 Jun 13; Vol. 6 (6), pp. 100600.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101769215 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6340 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666340%22">26666340 </searchLink><i>NLM ISO Abbreviation: </i>Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40516517
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.medj.2025.100600
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100600
    Titles:
      – TitleFull: More than just another IDH inhibitor: Insights from the HMPL-306 phase 1 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Getz TM
      – PersonEntity:
          Name:
            NameFull: Bewersdorf JP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 06
              Text: 2025 Jun 13
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2666-6340
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Med (New York, N.Y.)
              Type: main
ResultId 1